Skip to main content
NCBI home page
The British Journal of Cancer. Supplement logoLink to The British Journal of Cancer. Supplement
. 1990 Jul;10:52–56.

Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.

E Anagnostaki 1, D Skarlos 1, N Tamvakis 1, P Psaropoulou 1, E Blana 1, A Bamias 1, S Legaki 1, G Aravantinos 1, C Deliveliotis 1, K Dimopoulos 1
PMCID: PMC2149508  PMID: 2200496

Abstract

The antigenic expression of normal bladder epithelium and transitional carcinomas has been studied using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1. Tissues from 79 cases of bladder carcinoma and 11 cases of non-neoplastic bladder tissues were stained with both the haematoxylin-eosin (H/E) and the indirect two-stage immunoperoxidase methods using the monoclonal antibodies (MAbs) HMFG1 and AUA1 at a concentration of 25 micrograms ml-1. Positive and negative controls were also used. Moreover, 46 urine smears prepared after cytocentrifugation were stained with both the Papanicolaou and the indirect two-stage immunoperoxidase methods. The results showed that HMFG1 reacted with the majority of cases of grade III carcinomas and carcinomas in situ and with a subset only of low-grade (I and II) carcinomas. The pattern of staining showed the following characteristics: (1) the epithelial surface membrane stained both in normal bladder and bladder carcinomas (surface of the papillae), (2) a variant number of cancer cells, increasing with the degree of malignancy, showed membrane and/or cytoplasmic staining, (3) tumours of the same histological grade showed antigenic heterogeneity. The MAb AUA1 was not widely expressed. The immunocytochemical study confirmed the reaction of HMFG1 with a variant number of malignant urothelial cells exfoliated in urine. Their reaction with AUA1 was much more limited. The immunocytochemical staining seemed to be more sensitive in the detection of malignant cells in some cases which had been characterized as negative or suspicious for malignancy by the Papanicolaou examination. The intravesical treatment with chemotherapeutic agents did not seem to influence the antigenic expression of malignant urothelial cells.

Full text

PDF
52

Images in this article

53Figure 1
on p.53
53Figure 2
on p.53
53Figure 3
on p.53
54Figure 4
on p.54
54Figure 5
on p.54

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alroy J., Pauli B. U., Weinstein R. S. Correlation between numbers of desmosomes and the aggressiveness of transitional cell carcinoma in human urinary bladder. Cancer. 1981 Jan 1;47(1):104–112. doi: 10.1002/1097-0142(19810101)47:1<104::aid-cncr2820470118>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  2. Arklie J., Taylor-Papadimitrious J., Bodmer W., Egan M., Millis R. Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers. Int J Cancer. 1981 Jul 15;28(1):23–29. doi: 10.1002/ijc.2910280105. [DOI] [PubMed] [Google Scholar]
  3. Arndt R., Huland H. Biochemical and immunologic diagnosis of cancer. Urinary immunocytology and bladder carcinomas. Tumour Biol. 1987;8(2-3):105–105. [PubMed] [Google Scholar]
  4. Burchell J., Durbin H., Taylor-Papadimitriou J. Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. J Immunol. 1983 Jul;131(1):508–513. [PubMed] [Google Scholar]
  5. Chopin D. K., deKernion J. B., Rosenthal D. L., Fahey J. L. Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing. J Urol. 1985 Aug;134(2):260–265. doi: 10.1016/s0022-5347(17)47118-7. [DOI] [PubMed] [Google Scholar]
  6. Czerniak B., Koss L. G. Expression of Ca antigen on human urinary bladder tumors. Cancer. 1985 May 15;55(10):2380–2383. doi: 10.1002/1097-0142(19850515)55:10<2380::aid-cncr2820551013>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  7. Czerniak B., Koss L. G., Sherman A. Nuclear pores and DNA ploidy in human bladder carcinomas. Cancer Res. 1984 Sep;44(9):3752–3756. [PubMed] [Google Scholar]
  8. Decenzo J. M., Howard P., Irish C. E. Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma. J Urol. 1975 Dec;114(6):874–878. doi: 10.1016/s0022-5347(17)67163-5. [DOI] [PubMed] [Google Scholar]
  9. Emmott R. C., Javadpour N., Bergman S. M., Soares T. Correlation of the cell surface antigens with stage and grade in cancer of the bladder. J Urol. 1979 Jan;121(1):37–39. doi: 10.1016/s0022-5347(17)56650-1. [DOI] [PubMed] [Google Scholar]
  10. Epenetos A. A., Canti G., Taylor-Papadimitriou J., Curling M., Bodmer W. F. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. Lancet. 1982 Nov 6;2(8306):1004–1006. doi: 10.1016/s0140-6736(82)90047-2. [DOI] [PubMed] [Google Scholar]
  11. Epenetos A. A., Hooker G., Krausz T., Snook D., Bodmer W. F., Taylor-Papadimitriou J. Antibody-guided irradiation of malignant ascites in ovarian cancer: a new therapeutic method possessing specificity against cancer cells. Obstet Gynecol. 1986 Sep;68(3 Suppl):71S–74S. [PubMed] [Google Scholar]
  12. Fradet Y., Cordon-Cardo C., Thomson T., Daly M. E., Whitmore W. F., Jr, Lloyd K. O., Melamed M. R., Old L. J. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies. Proc Natl Acad Sci U S A. 1984 Jan;81(1):224–228. doi: 10.1073/pnas.81.1.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fradet Y., Cordon-Cardo C., Whitmore W. F., Jr, Melamed M. R., Old L. J. Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics. Cancer Res. 1986 Oct;46(10):5183–5188. [PubMed] [Google Scholar]
  14. Gendler S. J., Burchell J. M., Duhig T., Lamport D., White R., Parker M., Taylor-Papadimitriou J. Cloning of partial cDNA encoding differentiation and tumor-associated mucin glycoproteins expressed by human mammary epithelium. Proc Natl Acad Sci U S A. 1987 Sep;84(17):6060–6064. doi: 10.1073/pnas.84.17.6060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Grossman H. B. Hybridoma antibodies reactive with human bladder carcinoma cell surface antigens. J Urol. 1983 Sep;130(3):610–614. doi: 10.1016/s0022-5347(17)51324-5. [DOI] [PubMed] [Google Scholar]
  16. Hellström I., Rollins N., Settle S., Chapman P., Chapman W. H., Hellström K. E. Monoclonal antibodies to two mouse bladder carcinoma antigens. Int J Cancer. 1982 Feb 15;29(2):175–180. doi: 10.1002/ijc.2910290211. [DOI] [PubMed] [Google Scholar]
  17. Heyderman E., Brown B. M., Richardson T. C. Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase. J Clin Pathol. 1984 Dec;37(12):1363–1369. doi: 10.1136/jcp.37.12.1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Huffman J. L., Fradet Y., Cordon-Cardo C., Herr H. W., Pinsky C. M., Oettgen H. F., Old L. J., Whitmore W. F., Jr, Melamed M. R. Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder. Cancer Res. 1985 Oct;45(10):5201–5204. [PubMed] [Google Scholar]
  19. Masuko T., Yagita H., Hashimoto Y. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells. J Natl Cancer Inst. 1984 Mar;72(3):523–530. [PubMed] [Google Scholar]
  20. Messing E. M., Bubbers J. E., Whitmore K. E., deKernion J. B., Nestor M. S., Fahey J. L. Murine hybridoma antibodies against human transitional carcinoma-associated antigens. J Urol. 1984 Jul;132(1):167–172. doi: 10.1016/s0022-5347(17)49512-7. [DOI] [PubMed] [Google Scholar]
  21. Pectasides D., Stewart S., Courtenay-Luck N., Rampling R., Munro A. J., Krausz T., Dhokia B., Snook D., Hooker G., Durbin H. Antibody-guided irradiation of malignant pleural and pericardial effusions. Br J Cancer. 1986 Jun;53(6):727–732. doi: 10.1038/bjc.1986.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pocock R. D., Ibrahim S. K., Sloane J. P., Ponder B. A., Shearer R. J. Potential value of antisera to epithelial membrane antigen in detecting early invasion in transitional cell carcinoma. Br J Urol. 1983 Dec;55(6):670–675. doi: 10.1111/j.1464-410x.1983.tb03401.x. [DOI] [PubMed] [Google Scholar]
  23. Rearden A., Nachtsheim D. A., Frisman D. M., Chiu P., Elmajian D. A., Baird S. M. Altered cell surface antigen expression in bladder carcinoma detected by a new hemagglutinating monoclonal antibody. J Immunol. 1983 Dec;131(6):3073–3077. [PubMed] [Google Scholar]
  24. Sincock A. M., Middleton J., Moncrieff D. Towards an automated procedure for the quantitative cytological screening of cervical neoplasms. J Clin Pathol. 1983 May;36(5):535–538. doi: 10.1136/jcp.36.5.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sloane J. P., Ormerod M. G. Distribution of epithelial membrane antigen in normal and neoplastic tissues and it value in diagnostic tumor pathology. Cancer. 1981 Apr 1;47(7):1786–1795. doi: 10.1002/1097-0142(19810401)47:7<1786::aid-cncr2820470711>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  26. Soloway M. S. Selecting initial therapy for bladder cancer. Cancer. 1987 Aug 1;60(3 Suppl):502–513. doi: 10.1002/1097-0142(19870801)60:3+<502::aid-cncr2820601512>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  27. Spurr N. K., Durbin H., Sheer D., Parkar M., Bobrow L., Bodmer W. F. Characterization and chromosomal assignment of a human cell surface antigen defined by the monoclonal antibody AUAI. Int J Cancer. 1986 Nov 15;38(5):631–636. doi: 10.1002/ijc.2910380503. [DOI] [PubMed] [Google Scholar]
  28. Starling J. J., Sieg S. M., Beckett M. L., Schellhammer P. F., Ladaga L. E., Wright G. L., Jr Monoclonal antibodies to human prostate and bladder tumor-associated antigens. Cancer Res. 1982 Aug;42(8):3084–3089. [PubMed] [Google Scholar]
  29. Summers J. L., Coon J. S., Ward R. M., Falor W. H., Miller A. W., 3rd, Weinstein R. S. Prognosis in carcinoma of the urinary bladder based upon tissue blood group abh and Thomsen-Friedenreich antigen status and karyotype of the initial tumor. Cancer Res. 1983 Feb;43(2):934–939. [PubMed] [Google Scholar]
  30. Taylor-Papadimitriou J., Peterson J. A., Arklie J., Burchell J., Ceriani R. L., Bodmer W. F. Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture. Int J Cancer. 1981 Jul 15;28(1):17–21. doi: 10.1002/ijc.2910280104. [DOI] [PubMed] [Google Scholar]
  31. Timpte C. S., Eckhardt A. E., Abernethy J. L., Hill R. L. Porcine submaxillary gland apomucin contains tandemly repeated, identical sequences of 81 residues. J Biol Chem. 1988 Jan 15;263(2):1081–1088. [PubMed] [Google Scholar]
  32. Wilkinson M. J., Howell A., Harris M., Taylor-Papadimitriou J., Swindell R., Sellwood R. A. The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas. Int J Cancer. 1984 Mar 15;33(3):299–304. doi: 10.1002/ijc.2910330304. [DOI] [PubMed] [Google Scholar]
  33. Young A. K., Hammond E., Middleton A. W., Jr The prognostic value of cell surface antigens in low grade, non-invasive, transitional cell carcinoma of the bladder. J Urol. 1979 Oct;122(4):462–464. doi: 10.1016/s0022-5347(17)56462-9. [DOI] [PubMed] [Google Scholar]
  34. Young D. A., Prout G. R., Jr, Lin C. W. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens. Cancer Res. 1985 Sep;45(9):4439–4446. [PubMed] [Google Scholar]

Articles from The British Journal of Cancer. Supplement are provided here courtesy of Cancer Research UK

RESOURCES